ITGAV and neoplasm: Among the 30 tumor samples, 7 (23.3%) were negative and 23 (76.7%) were positive in immunohistochemistry.We performed IHC to test ITGAV protein expression in LGG tissues and their counterparts and to examine the expression of ITGAV in LGG.